1. Head-to-head comparison of micafungin versus caspofungin in the treatment of invasive candidiasis

   • Michael A. Pfaller

   Clinical Trials Report 26 August 2009 Pages: 127 - 128

2. Genetic factors associated with susceptibility to invasive aspergillosis

   • Stuart M. Levitz

   Clinical Trials Report 26 August 2009 Pages: 129 - 130

3. Updates in antifungal susceptibility testing of filamentous fungi

   • Ana Espinel-Ingroff
   • Emilia Canton
   • Javier Peman

   OriginalPaper 26 August 2009 Pages: 133 - 141

4. Susceptibility testing of dermatophytes

   • Mahmoud A. Ghannoum
   • Nancy C. Isham
   • David V. Chand

   OriginalPaper 26 August 2009 Pages: 142 - 146

5. Can fungal biomarkers be used to improve antifungal therapy in the intensive care unit?

   • Luis Ostrosky-Zeichner

   OriginalPaper 26 August 2009 Pages: 147 - 151

6. Rare and emerging Candida species

   • Elizabeth M. Johnson

   OriginalPaper 26 August 2009 Pages: 152 - 159

7. Genetic basis of antifungal drug resistance

   • Chelsea Marie
   • Theodore C. White

   OriginalPaper 26 August 2009 Pages: 163 - 169

8. Fungal taxonomy: New developments in medically important fungi

   • Teun Boekhout
   • Cécile Gueidan
   • Grit Walther

   OriginalPaper 26 August 2009 Pages: 170 - 178

9. Recognition of the fungal cell wall by innate immune receptors

   • Stuart M. Levitz
   • Charles A. Specht

   OriginalPaper 26 August 2009 Pages: 179 - 185

10. Augmentation of innate host defenses against opportunistic fungal pathogens

    • Shmuel Shoham
    • Emmanuel Roilides
    • Thomas J. Walsh

    OriginalPaper 26 August 2009 Pages: 186 - 191